Could a second round of chemo after liver surgery keep cancer away?
NCT ID NCT06501482
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study looks at people with colorectal cancer that spread to the liver. After successful liver surgery and a good response to initial chemotherapy, half the participants will restart chemotherapy (FOLFIRI) and half will receive no further treatment. The goal is to see if restarting chemo improves the chance of staying cancer-free for 3 years. About 254 adults from French hospitals will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Kremlin Bicêtre
RECRUITINGParis, Île-de-France Region, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.